AB

Aman Bansal

Active Director Director DIN 08363368
DIN 08363368 First appointment Feb 2019 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Feb 2019
Shareholding value Locked Premium profile

About Aman Bansal

Aman Bansal has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Biostem Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08363368
Primary Designation Director
First Appointment 14 Feb 2019
Oldest Company Age 7 yrs

Current companies

Company Designation Appointment Founded Status
Biostem Pharma Private Limited U24290HR2019PTC078557
Director 14 Feb 2019 2019 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Biostem Pharma Private Limited
Premium access

Shareholding and investment profile for Aman Bansal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aman Bansal

Aman Bansal has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Biostem Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Aman Bansal is associated with 1 company as Director.

Aman Bansal has expertise in General Business.

Aman Bansal has 7 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available